Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.The staff at Acorda Therapeutics come from unusually diverse demographic backgrounds. The company is 42.5% female and 42.1% ethnic minorities. Despite its diversity in other areas, Acorda Therapeutics employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 93.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Acorda Therapeutics has great employee retention with staff members usually staying with the company for 4.6 years.The average employee at Acorda Therapeutics makes $97,279 per year, which is competitive for its industry and location. Some of its highest paying competitors, Exelixis, Gilead Sciences, and Vertex Pharmaceuticals, pay $108,978, $99,828, and $95,952, respectively.Based in New York, Acorda Therapeutics is a medium-sized health care company with 344 employees and a revenue of $118.0M.
Acorda Therapeutics's Mission Statement
To develop therapies that restore function and improve the lives of people with neurological disorders.
-
Acorda Therapeutics employee reviews
Be the first to review!
Do you work at Acorda Therapeutics?
Help job seekers learn about working at Acorda Therapeutics
The founders of Acorda Therapeutics is Ronald Cohen.
The key people at Acorda Therapeutics is Ronald Cohen.
Key People
R
Ronald Cohen
Acorda Therapeutics Rankings
Acorda Therapeutics is ranked #76 on the Best Health Care Companies to Work For in New York list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average an Acorda Therapeutics salary in the United States is $97,279 per year.
Acorda Therapeutics employees in the top 10 percent can make over $171,000 per year,
while Acorda Therapeutics employees at the bottom 10 percent earn less than $55,000 per year.
Average Acorda Therapeutics Salary
$97,279
yearly
$46.77 hourly
Updated March 14, 2024
And if you're looking for a job, here are the top jobs Acorda Therapeutics is hiring right now:
Partner
Marketing Director
Regional Business Director
Medical Science Liaison
Area Business Manager
Rate the Acorda Therapeutics' inclusivity.
Acorda Therapeutics diversity
9.4
Diversity Score
We calculated Acorda Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Acorda Therapeutics’s workforce.
Acorda Therapeutics diversity summary. Zippia estimates Acorda Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Acorda Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Acorda Therapeutics's workforce.
Acorda Therapeutics has 344 employees.
42% of Acorda Therapeutics employees are women, while 58% are men.
The most common ethnicity at Acorda Therapeutics is White (58%).
17% of Acorda Therapeutics employees are Hispanic or Latino.
11% of Acorda Therapeutics employees are Asian.
The average employee at Acorda Therapeutics makes $97,279 per year.
Acorda Therapeutics employees are most likely to be members of the democratic party.
Employees at Acorda Therapeutics stay with the company for 4.6 years on average.
A
Do you work at Acorda Therapeutics?
Were you satisfied with Acorda Therapeutics' salary and benefits?
Acorda Therapeutics Financial Performance
8.9
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Acorda Therapeutics currently has 118.6M in revenue. Acorda Therapeutics's most recent quarter produced 29.7m (q2'2023).
Acorda Therapeutics annual revenue
$588M
$471M
$353M
$235M
$118M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Highest paying Acorda Therapeutics competitors
Compare Acorda Therapeutics salaries to competitors, including Exelixis, Gilead Sciences, and Vertex Pharmaceuticals. Employees at Exelixis earn the highest average yearly salary of $108,978. The salaries at Gilead Sciences average $99,828 per year, and the salaries at Vertex Pharmaceuticals come in at $95,952 per year.
Zippia gives an in-depth look into the details of Acorda Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Acorda Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Acorda Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Acorda Therapeutics. The data presented on this page does not represent the view of Acorda Therapeutics and its employees or that of Zippia.
Acorda Therapeutics may also be known as or be related to Acorda Therapeutics, Acorda Therapeutics Inc, Acorda Therapeutics Inc. and Acorda Therapeutics, Inc.
